Atenolol (Page 6 of 6)
Cessation of Therapy in Patients With Angina Pectoris
If withdrawal of atenolol tablet therapy is planned, it should be achieved gradually and patients should be carefully observed and advised to limit physical activity to a minimum.
HOW SUPPLIED
Atenolol tablets USP, 25 mg (White to off-white marble finish, round, flat beveled edge tablets. Debossed with “TEVA” on one side and with “787” on the other side.) are supplied in
NDC: 70518-0399-00 90 in 1 BOTTLE PLASTIC
NDC: 70518-0399-01 100 in 1 BOTTLE PLASTIC
NDC: 70518-0399-02 30 in 1 BLISTER PACK
Repackaged and Distributed By:
Remedy Repack, Inc.
625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762
Storage
Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].
Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required).
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
PRINCIPAL DISPLAY PANEL
DRUG: Atenolol
GENERIC: Atenolol
DOSAGE: TABLET
ADMINSTRATION: ORAL
NDC: 70518-0399-0
NDC: 70518-0399-1
NDC: 70518-0399-2
COLOR: white
SHAPE: ROUND
SCORE: No score
SIZE: 6 mm
IMPRINT: 787;TEVA
PACKAGING: 90 in 1 BOTTLE, PLASTIC
PACKAGING: 100 in 1 BOTTLE, PLASTIC
PACKAGING: 30 in 1 BLISTER PACK
ACTIVE INGREDIENT(S):
- ATENOLOL 25mg in 1
INACTIVE INGREDIENT(S):
- CELLULOSE, MICROCRYSTALLINE
- POVIDONE K30
- MAGNESIUM STEARATE
- SODIUM STARCH GLYCOLATE TYPE A POTATO
| ATENOLOL atenolol tablet | |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| Labeler — REMEDYREPACK INC. (829572556) |
Revised: 01/2021 REMEDYREPACK INC.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.